Companies manufacturing new drugs to combat illnesses from the flu to AIDS are at risk of losing their patent rights.  Supporters of this say it will make drugs cheaper and more plentiful.  Stripping drug companies of this financial security, however, removes the incentive for them … Continue reading Underserved and Overlooked, by Bishop Council Nedd II